These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26002934)

  • 21. A micro-RNA expression signature for human NAFLD progression.
    Guo Y; Xiong Y; Sheng Q; Zhao S; Wattacheril J; Flynn CR
    J Gastroenterol; 2016 Oct; 51(10):1022-30. PubMed ID: 26874844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease.
    Panera N; Gnani D; Crudele A; Ceccarelli S; Nobili V; Alisi A
    World J Gastroenterol; 2014 Nov; 20(41):15079-86. PubMed ID: 25386056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of microRNAs in immunopathogenesis of non-alcoholic fatty liver disease revealed by integrated analysis of microRNA and mRNA expression profiles.
    Zhang YJ; Hu Y; Li J; Chi YJ; Jiang WW; Zhang F; Liu YL
    Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):65-79. PubMed ID: 28119261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics in twins with Crohn's disease: less pronounced than previously believed?
    Halfvarson J
    Inflamm Bowel Dis; 2011 Jan; 17(1):6-12. PubMed ID: 20848478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased Serum miR-1296 may Serve as an Early Biomarker for the Diagnosis of Non-Alcoholic Fatty Liver Disease.
    Yu F; Wang X; Zhao H; Hao Y; Wang W
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease.
    Braza-Boïls A; Marí-Alexandre J; Molina P; Arnau MA; Barceló-Molina M; Domingo D; Girbes J; Giner J; Martínez-Dolz L; Zorio E
    Liver Int; 2016 Aug; 36(8):1221-9. PubMed ID: 26901384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.
    Yamada H; Suzuki K; Ichino N; Ando Y; Sawada A; Osakabe K; Sugimoto K; Ohashi K; Teradaira R; Inoue T; Hamajima N; Hashimoto S
    Clin Chim Acta; 2013 Sep; 424():99-103. PubMed ID: 23727030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond.
    Lin HY; Yang YL; Wang PW; Wang FS; Huang YH
    Cells; 2020 Apr; 9(4):. PubMed ID: 32331364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miRNA-103: molecular link between insulin resistance and nonalcoholic fatty liver disease.
    Xu Q; Li Y; Shang YF; Wang HL; Yao MX
    World J Gastroenterol; 2015 Jan; 21(2):511-6. PubMed ID: 25593466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences of microRNA expression profiles between monozygotic twins' blood samples.
    Xiao C; Pan C; Liu E; He H; Liu C; Huang Y; Yi S; Huang D
    Forensic Sci Int Genet; 2019 Jul; 41():152-158. PubMed ID: 31132533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating microRNAs in nonalcoholic fatty liver disease.
    DiStefano JK; Gerhard GS
    Expert Rev Gastroenterol Hepatol; 2016; 10(2):161-3. PubMed ID: 26606259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease.
    Okamoto K; Koda M; Okamoto T; Onoyama T; Miyoshi K; Kishina M; Matono T; Kato J; Tokunaga S; Sugihara T; Hiramatsu A; Hyogo H; Tobita H; Sato S; Kawanaka M; Hara Y; Hino K; Chayama K; Murawaki Y; Isomoto H
    PLoS One; 2020; 15(2):e0219412. PubMed ID: 32106257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating miR-29b positively correlates with non-alcoholic fatty liver disease in a Chinese population.
    He Z; Yang JJ; Zhang R; Li HT; Wu L; Jiang F; Jia WP; Hu C
    J Dig Dis; 2019 Apr; 20(4):189-195. PubMed ID: 30756471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased MiR-155 Level in the Peripheral Blood of Non-Alcoholic Fatty Liver Disease Patients may Serve as a Biomarker and may Influence LXR Activity.
    Wang L; Zhang N; Wang Z; Ai DM; Cao ZY; Pan HP
    Cell Physiol Biochem; 2016; 39(6):2239-2248. PubMed ID: 27832630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of MR proton density fat fraction and its correlation with ultrasonography and biochemical markers in nonalcoholic fatty liver disease in overweight adolescents.
    Netaji A; Jain V; Gupta AK; Kumar U; Jana M
    J Pediatr Endocrinol Metab; 2020 Apr; 33(4):473-479. PubMed ID: 32146441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic silencing of microRNA-125b-5p promotes liver fibrosis in nonalcoholic fatty liver disease via integrin α8-mediated activation of RhoA signaling pathway.
    Cai Q; Chen F; Xu F; Wang K; Zhang K; Li G; Chen J; Deng H; He Q
    Metabolism; 2020 Mar; 104():154140. PubMed ID: 31926204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease.
    Soronen J; Yki-Järvinen H; Zhou Y; Sädevirta S; Sarin AP; Leivonen M; Sevastianova K; Perttilä J; Laurila PP; Sigruener A; Schmitz G; Olkkonen VM
    Physiol Rep; 2016 Jan; 4(1):. PubMed ID: 26733244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver Fat and Insulin Sensitivity Define Metabolite Profiles During a Glucose Tolerance Test in Young Adult Twins.
    Rämö JT; Kaye SM; Jukarainen S; Bogl LH; Hakkarainen A; Lundbom J; Lundbom N; Rissanen A; Kaprio J; Matikainen N; Pietiläinen KH
    J Clin Endocrinol Metab; 2017 Jan; 102(1):220-231. PubMed ID: 27809652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.
    Traussnigg S; Kienbacher C; Gajdošík M; Valkovič L; Halilbasic E; Stift J; Rechling C; Hofer H; Steindl-Munda P; Ferenci P; Wrba F; Trattnig S; Krššák M; Trauner M
    Liver Int; 2017 Oct; 37(10):1544-1553. PubMed ID: 28544208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery.
    Xanthakos SA; Jenkins TM; Kleiner DE; Boyce TW; Mourya R; Karns R; Brandt ML; Harmon CM; Helmrath MA; Michalsky MP; Courcoulas AP; Zeller MH; Inge TH;
    Gastroenterology; 2015 Sep; 149(3):623-34.e8. PubMed ID: 26026390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.